The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCc Japan Regulatory News (CCJI)

Share Price Information for Cc Japan (CCJI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 190.50
Bid: 189.00
Ask: 191.50
Change: 1.50 (0.79%)
Spread: 2.50 (1.323%)
Open: 188.00
High: 192.00
Low: 188.00
Prev. Close: 189.00
CCJI Live PriceLast checked at -
CC Japan Income & Growth is an Investment Trust

To provide Shareholders with dividend income combined with capital growth, mainly through investment in equities listed or quoted in Japan.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Appointments

16 Dec 2021 07:00

RNS Number : 8112V
CC Japan Income & Growth Trust PLC
16 December 2021
 

 

CC Japan Income & Growth Trust plc (the "Company")

Director Appointments

The Board of CC Japan Income & Growth Trust plc is pleased to announce the appointments of Craig Cleland and June Aitken as Non-Executive Directors of the Company with effect from 1 February 2022.

June has over 30 years of experience of Asian and global equity markets as an institutional stockbroker. She has held numerous senior roles at HSBC Bank plc, London, including as Global Head of Emerging Market Equity Distribution and Head of Strategy Management. Previously, June was a Managing Director at UBS (AG), Head of Global Equity Product and Global Head of Asian Equities. June initially worked as a stockbroker specialising in Asian equity sales with WI Carr and County NatWest Securities. June holds a BA degree in PPE from Oxford University.

June has also held diverse board appointments including HSBC Bank Japan. She is currently a Non-Executive Director of both JPMorgan Asia Growth and Income plc and Greengage Global Holding. She is Chair of PEAL Capital Partners UK Limited and principal of Elemental Partners LLP, consultants.

June currently holds 40,000 Ordinary Shares in the Company.

Craig has over 35 years of investment trust and fund management experience. Since 2013, he has been Head of Corporate Development/Investment Trusts at CQS (UK) LLP, a multi-asset asset management firm in London business with a focus on credit markets. He is also a Non-Executive Director of Invesco Perpetual Select Trust plc and BlackRock Latin American Investment Trust. Craig also served as a member of the AIC Technical Committee for 10 years and is an Associate of the Institute of Bankers in Scotland.

Previously, Craig was a Managing Director at JPMorgan Asset Management (UK) Limited as a Client Director of their investment trust business. He was also Director and Senior Company Secretary at Fleming Investment Trust Management, transferring to JPMorgan Chase after the acquisition of Robert Fleming Holdings Limited.

Craig does not currently hold any shares in the Company.

Harry Wells, Chairman, commented:

"We are delighted to welcome both June and Craig to the Board. They bring a wealth of oversight and board experience besides familiarity with Japan and investment markets. We are confident that they will both make a valuable contribution to the Company.

Mr John Scott, who has served as a Non- Executive Director since the launch of the Company in December 2015, will retire from the board at the March Annual General Meeting.

There is no information to be disclosed in respect of paragraphs 9.6.13(2) to 9.6.13(6) of the Financial Conduct Authority's Listing Rules for Ms Aitken or Mr Cleland.

Enquiries:

Company Secretary 020 3327 9720

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATABPTMTABBPB
Date   Source Headline
30th Apr 202412:42 pmRNSNet Asset Value(s)
29th Apr 20241:07 pmRNSNet Asset Value(s)
26th Apr 202412:43 pmRNSNet Asset Value(s)
25th Apr 202411:23 amRNSNet Asset Value(s)
24th Apr 202412:08 pmRNSNet Asset Value(s)
23rd Apr 20241:21 pmRNSNet Asset Value(s)
22nd Apr 202411:26 amRNSNet Asset Value(s)
19th Apr 202412:41 pmRNSNet Asset Value(s)
18th Apr 202411:16 amRNSNet Asset Value(s)
18th Apr 20247:00 amRNSKepler Trust Intelligence: New Research
17th Apr 202411:28 amRNSNet Asset Value(s)
16th Apr 202412:29 pmRNSNet Asset Value(s)
15th Apr 20242:38 pmRNSPortfolio Update
15th Apr 20241:51 pmRNSMonthly Factsheet
15th Apr 202411:50 amRNSNet Asset Value(s)
12th Apr 202411:57 amRNSNet Asset Value(s)
11th Apr 202411:28 amRNSNet Asset Value(s)
10th Apr 202411:53 amRNSNet Asset Value(s)
9th Apr 202410:15 amRNSNet Asset Value(s)
8th Apr 202411:29 amRNSNet Asset Value(s)
8th Apr 202411:26 amRNSDirector/PDMR Shareholding
5th Apr 202412:07 pmRNSNet Asset Value(s)
4th Apr 20241:13 pmRNSNet Asset Value(s)
3rd Apr 202412:02 pmRNSNet Asset Value(s)
2nd Apr 20241:01 pmRNSNet Asset Value(s)
28th Mar 202412:42 pmRNSNet Asset Value(s)
27th Mar 20241:35 pmRNSNet Asset Value(s)
26th Mar 202411:57 amRNSNet Asset Value(s)
25th Mar 202411:32 amRNSNet Asset Value(s)
22nd Mar 202412:03 pmRNSNet Asset Value(s)
21st Mar 202411:06 amRNSNet Asset Value(s)
20th Mar 202411:37 amRNSNet Asset Value(s)
19th Mar 20241:05 pmRNSNet Asset Value(s)
18th Mar 202412:32 pmRNSNet Asset Value(s)
15th Mar 202412:13 pmRNSNet Asset Value(s)
14th Mar 20243:18 pmRNSPortfolio Update
14th Mar 20242:30 pmRNSMonthly Factsheet
14th Mar 202412:51 pmRNSNet Asset Value(s)
13th Mar 20246:05 pmRNSHolding(s) in Company
13th Mar 202412:34 pmRNSNet Asset Value(s)
12th Mar 202411:54 amRNSNet Asset Value(s)
11th Mar 202412:03 pmRNSNet Asset Value(s)
8th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
8th Mar 202411:28 amRNSNet Asset Value(s)
7th Mar 202412:12 pmRNSNet Asset Value(s)
6th Mar 20242:51 pmRNSNet Asset Value(s)
5th Mar 20245:20 pmRNSDirector/PDMR Shareholding
5th Mar 20245:10 pmRNSResult of AGM and Notification of Board Changes
5th Mar 202412:21 pmRNSNet Asset Value(s)
4th Mar 202412:17 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.